ES2052730T3 - Mejoras en o relativas a antagonistas de leucotrienos. - Google Patents

Mejoras en o relativas a antagonistas de leucotrienos.

Info

Publication number
ES2052730T3
ES2052730T3 ES88307429T ES88307429T ES2052730T3 ES 2052730 T3 ES2052730 T3 ES 2052730T3 ES 88307429 T ES88307429 T ES 88307429T ES 88307429 T ES88307429 T ES 88307429T ES 2052730 T3 ES2052730 T3 ES 2052730T3
Authority
ES
Spain
Prior art keywords
group
formula
ring
leucotrene
relative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88307429T
Other languages
English (en)
Inventor
Winston Stanley Marshall
Sandra Kay Sigmund
Celia Ann Whitesitt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2052730T3 publication Critical patent/ES2052730T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA INVENCION SE REFIERE A TETRAZOLES DISUSTITUIDOS QUE ANTAGONIZAN EL EFECTO DE LEUCOTRIENOS C4, D4 O E4 O CUALQUIER COMBINACION DE ESTO EN TEJIDOS SELECCIONADOS, QUE SON DE LA FORMULA(I) DONDE R1 ES C1 AC8 ALQUILO O FENILO; R2 ES C3 A C10 ALQUILIDENO O FENILO; [TET] ES UN ANILLO 1H O 2H TETRAZOLITO DISUSTITUIDO, DE FORMULA(II); L2 ES 1)UN GRUPO ALQUILIDENO C1 A C10, O 2) UN GRUPO BENCILO DE LA FORMULA(III) DONDE R7 ES UN ATOMO DE HIDROGENO, GRUPO HIDROXI O ACETOXI, Y N ES DE 0 A 3; Y EL GRUPO METILENO UNICO UNIDO AL ANILLO ESTA TAMBIEN UNIDO AL ANILLO TETRAZOLITO[TET]; O UNA SAL FARMACEUTICAMENTE ACEPTABLE DE ESTO.
ES88307429T 1987-08-14 1988-08-11 Mejoras en o relativas a antagonistas de leucotrienos. Expired - Lifetime ES2052730T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/085,588 US4820723A (en) 1987-08-14 1987-08-14 Disubstituted tetrazole leukotriene antagonists and methods for their use thereas

Publications (1)

Publication Number Publication Date
ES2052730T3 true ES2052730T3 (es) 1994-07-16

Family

ID=22192636

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88307429T Expired - Lifetime ES2052730T3 (es) 1987-08-14 1988-08-11 Mejoras en o relativas a antagonistas de leucotrienos.

Country Status (14)

Country Link
US (1) US4820723A (es)
EP (1) EP0303478B1 (es)
JP (1) JPS6466174A (es)
KR (1) KR890003716A (es)
CN (1) CN1012434B (es)
AU (1) AU610218B2 (es)
DE (1) DE3875030T2 (es)
DK (1) DK449388A (es)
ES (1) ES2052730T3 (es)
HU (1) HUT50462A (es)
NZ (1) NZ225791A (es)
PH (1) PH26259A (es)
PT (1) PT88244B (es)
ZA (1) ZA885887B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820722A (en) * 1987-08-14 1989-04-11 Eli Lilly And Company Disubstituted tetrazoles and their use as leukotriene antagonists
EP0408509B1 (de) * 1989-07-14 1996-03-06 Ciba-Geigy Ag Substituierte Benzonitrile
DE4124942A1 (de) * 1991-07-27 1993-01-28 Thomae Gmbh Dr K 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CN101544614B (zh) * 2008-03-24 2011-07-20 合肥合源药业有限公司 磷酸二酯酶ⅲ抑制剂、其制法及其医药用途
NZ719169A (en) 2013-12-20 2018-08-31 Novartis Ag Heteroaryl butanoic acid derivatives as lta4h inhibitors
CN112513026B (zh) 2018-07-31 2025-02-25 诺华股份有限公司 Lta4h抑制剂的晶型

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661505A (en) * 1982-11-03 1987-04-28 Eli Lilly And Company Leukotriene antagonists
US4663332A (en) * 1985-10-10 1987-05-05 Hoffman-La Roche Inc. 5-substituted N-alkylated tetrazoles
PT85110A (en) * 1986-06-23 1987-07-01 Merck Frosst Canada Inc Process for preparing benzenealkanoic acid derivatives useful as leukotriene antagonists
CA1315279C (en) * 1987-01-12 1993-03-30 Nancy Grace Bollinger Anti-inflammatory agents

Also Published As

Publication number Publication date
PT88244B (pt) 1995-03-01
DE3875030D1 (de) 1992-11-05
EP0303478A1 (en) 1989-02-15
US4820723A (en) 1989-04-11
AU2096788A (en) 1989-02-16
JPS6466174A (en) 1989-03-13
EP0303478B1 (en) 1992-09-30
KR890003716A (ko) 1989-04-17
HUT50462A (en) 1990-02-28
CN1031224A (zh) 1989-02-22
DE3875030T2 (de) 1993-03-04
ZA885887B (en) 1990-04-25
PT88244A (pt) 1989-06-30
CN1012434B (zh) 1991-04-24
PH26259A (en) 1992-04-01
DK449388D0 (da) 1988-08-11
DK449388A (da) 1989-02-15
AU610218B2 (en) 1991-05-16
NZ225791A (en) 1990-10-26

Similar Documents

Publication Publication Date Title
ES2143238T3 (es) Derivados de 1-(piperidinil disustituido en posiciones 1,2)-piperazinas sustituidas en posicion 4.
ATE225782T1 (de) Benzopyranderivate
PE108898A1 (es) Derivados 6,5-heterobiciclicos sustituidos
ES2155995T3 (es) Compuestos de 4-fenilpiperidina.
DE69705829D1 (de) Meta-substituierte phenylsulphonamidderivate
EA199700117A1 (ru) Трициклические бензазепиновые антагонисты вазопрессина, способ их получения, фармацевтическая композиция и способ лечения млекопитающих с использованием трициклических бензазепинов
CO5140068A1 (es) Nuevas composiciones de medicamentos a base de compuestos anticolinergicamente activos y -mimeticos
CO5011115A1 (es) Compuestos y metodos quimioquina
ES538418A0 (es) Un derivado de indol-3-carboxamida
DE69132713D1 (de) Benzylidenthiazolidinderivate, ihre Herstellung und ihre Anwendung als Lipidperoxid-Inhibitoren
EA200000400A1 (ru) Галогензамещенные тетрациклические производные тетрагидрофурана
ES2123873T3 (es) Pirrolocarbazol.
MY129176A (en) Tetrahydro gamma-carbolines
ES2052730T3 (es) Mejoras en o relativas a antagonistas de leucotrienos.
NO20004609L (no) Desinfiseringssammensetning
ES2106936T3 (es) Derivados de carbazolona y procedimientos para su preparacion.
ES2055867T3 (es) Derivados de dibenzotiazepina utiles como agentes antiespasmodicos.
ES2177727T3 (es) Derivados de 4-indolilpiperazinilo.
MX9306529A (es) Derivados de pirazol condensado, metodo para fabricarlos y composicion farmaceutica que los contiene
ECSP941050A (es) Derivados de benzofurano, proceso para su preparacion y composicion farmaceutica que los contiene
ES2195089T3 (es) Benzotiofenos amorfos, procedimientos de preparacion y uso.
ES2059396T3 (es) Derivados de indeno y metodos.
AR027035A1 (es) Pirroles sustituidos
ES2038159T3 (es) Procedimiento para preparar derivados sustituidos de 2-aminoacetamida.
ATE113949T1 (de) Alpha-adrenergische rezeptorantagonisten.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 303478

Country of ref document: ES